University of Chicago
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Chicago sits in the top decile of US sponsors by registered trial count (#41 of 15,742 sponsors by registered trial count).
University of Chicago: 796 sponsored US clinical trials, 158 recruiting.
University of Chicago sponsors 796 registered US clinical trials on ClinicalTrials.gov, 158 of them currently recruiting, and 451 completed. 67 of these trials are in Phase 3-4 (later-stage) and 293 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Prostate Cancer, with 11 trials.
Top-decile sponsor footprint
University of Chicago ranks in the top decile of sponsors by registered trial count (#41 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
451 of 562 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (80.2%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
796 total, page 5 of 16
Study of PD1 Blockade by Pembrolizumab With Stereotactic Body Radiotherapy in Advanced Solid Tumors
NCT02608385
Pembrolizumab in Treating Patients With Malignant Mesothelioma
NCT02399371
Metformin and Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
NCT02122185
Thirty Million Words Home Visiting
NCT02216032
Vasopressor SAT Study
NCT03182335
Assessment of Paclitaxel-Induced Neuropathy
NCT01953159
Immune Resolution After Staphylococcus Aureus Bacteremia
NCT01879761
Carfilzomib, Lenalidomide, and Dexamethasone Before and After Stem Cell Transplant in Treating Patients With Newly Diagnosed Multiple Myeloma
NCT01816971
Comprehensive Care Physician: Integrated Inpatient and Outpatient Care for Patients at High Risk of Hospitalization
NCT01929005
The Effects of Vertical Position on Gas Exchange in Patients With Respiratory Failure
NCT01705119
Outcome of BCF Access in Hemodialysis Patients
NCT01693263
Feasibility of Hormones and Radiation for Intermediate or High Risk Prostate Cancer
NCT01342367
Use of Ultrasonography to Determine Fluid-responsiveness for Shock in a Population of Intensive Care Unit Patients
NCT01680770
Genetic Factors in Chronic Sinusitis
NCT00880516
A Multi Modality Surveillance Program for Women At High Risk for Breast Cancer
NCT00989638
Evaluation of TEACH (Training Early Achievers for Careers in Health) Research
NCT00204035
Chicago Social Drinking Project
NCT00961792
Allogenic Islet Cell Transplantation
NCT00160732
Diffusion of Use of Low Molecular Weight Heparin for Thrombosis on the Medicine Services
NCT00203970
Mobile Health Management of Hypertension
NCT05856955
A Trial of Locoregionally Advanced Squamous Cell Carcinoma of The Head and Neck
NCT07346196
Study to Understand Relationship Between Gut Health and Toxicities of Hormonal Breast Cancer Treatment
NCT07553234
The Effect of Apple Cider Vinegar Supplementation on 24-hour Urine Chemistry in Adults
NCT07389226
Evaluating Treatment Outcomes Using Darolutamide and Androgen Deprivation Therapy in Patients With Metastatic Hormone-Sensitive Prostate Cancer.
NCT06660862
Effects of Stimulant Medications in PTSD
NCT07664631
Biasing Food Value Construction
NCT07692945
Radiation to Treat Joint Damage Caused by Cancer Immunotherapy
NCT07478679
Collagenase Biobank Study
NCT07211230
The FLOW Registry.
NCT07430423
BRIDGE-US: Bridging Readiness in Deployed Neurotrauma Gaps for Excellence
NCT07636213
A Study Evaluating the Immunotherapy Treatment for Ovarian Cancer and Other Advanced Malignancies.
NCT07389239
Aripiprazole in Body Focused Repetitive Behaviors
NCT05545891
Outpatient Visits Versus Telehealth for Postoperative Care After Minimally Invasive Gynecologic Surgery
NCT07420114
Can 3D Modeling Enhance Patient Understanding, Education, and Surgical Outcomes in Gender Affirming Peritoneal Vaginoplasty?
NCT07412509
Digital Support for Mental Health Intervention in Patients With Inflammatory Bowel Disease
NCT06575660
Pragmatic Use of PAIN-Advanced Dementia Scale in Emergency Departments
NCT06370572
Effects of Drugs on Stress Memories
NCT06471647
Single Port Insufflation RCT
NCT06990750
Localized Body Cooling Technology on Sleep and Metabolism in African, American With Overweight and Obesity
NCT05849181
Evaluating Femoral Traction
NCT06160804
Sleep Extension or Regularity to Reduce Diabetes Risk
NCT06128265
Psilocybin in Co-occuring Major Depressive Disorder and Borderline Personality Disorder
NCT05399498
A Mobile Health (mHealth) Strategy for Improving Blood Pressure Control Among Adult Hypertensive African Americans
NCT06078540
Prosocial Effects of MDMA
NCT05948683
Parent-to-parent Coaching While Awaiting Hospital Discharge With a Child With a Ventilator
NCT05880953
The Hemodynamic Effects of SGLT2i in Acute Decompensated Heart Failure
NCT05346653
Caplyta in Borderline Personality Disorder
NCT05356013
Mitigating Post-Op RV Dysfunction After LVAD Implantation
NCT05758194
Autologous Fat Grafting in Radiated Soft Tissue Reconstruction
NCT05890196
Studying Malnutrition And Sarcopenia In Older Adults With Acute Myeloid Leukemia
NCT05458258
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 137 |
| Phase 2 | 156 |
| Phase 3 | 14 |
| Phase 4 | 53 |
Therapeutic Areas
What is open in the University of Chicago pipeline
158 recruiting of 796 indexed (20% open); 451 completed (57%).
Phase mix: 67 late (III/IV) vs 293 early (I/II) (early-phase heavy).
Top condition: Prostate Cancer (11 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Chicago: open-pipeline peers nationwide
Peers matched on 796 registered trials and 20% open enrollment, not the therapeutic-area sidebar.
University of Chicago sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 796 trials (± recruiting share)
- Dana-Farber Cancer Institute · 781 trials · 14% recruiting
- University of California, San Diego · 775 trials · 18% recruiting
- University of Utah · 818 trials · 17% recruiting
- University of Texas Southwestern Medical Center · 837 trials · 19% recruiting
Sponsors near 20% open enrollment (± trial volume)
- Acera Surgical · 20% recruiting · 5 trials
- Align Technology · 20% recruiting · 5 trials
- AltruBio · 20% recruiting · 5 trials
- Alvernia University · 20% recruiting · 5 trials
Related
What to do with this University of Chicago page
796 registered trials is a research-attention snapshot, not an endorsement of University of Chicago or any single study.
- 158 of University of Chicago's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Prostate Cancer is the condition University of Chicago studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Prostate Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Chicago pipeline card: 796 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.